盐酸艾司洛尔结构式
|
常用名 | 盐酸艾司洛尔 | 英文名 | Esmolol hydrochloride |
---|---|---|---|---|
CAS号 | 81161-17-3 | 分子量 | 331.835 | |
密度 | 1.026 | 沸点 | 430.2ºC at 760 mmHg | |
分子式 | C16H26ClNO4 | 熔点 | 48-50ºC | |
MSDS | 美版 | 闪点 | 214ºC | |
符号 |
GHS07 |
信号词 | Warning |
盐酸艾司洛尔用途Esmolol盐酸盐是一种β肾上腺素受体抑制剂。 |
中文名 | 盐酸艾司洛尔 |
---|---|
英文名 | esmolol hydrochloride |
中文别名 | 4-{[3-(1-甲基乙基氨基)-2-羟基]丙氧基}苯丙酸甲酯盐酸盐 | 半水盐酸阿扑吗啡 |
英文别名 | 更多 |
密度 | 1.026 |
---|---|
沸点 | 430.2ºC at 760 mmHg |
熔点 | 48-50ºC |
分子式 | C16H26ClNO4 |
分子量 | 331.835 |
闪点 | 214ºC |
精确质量 | 331.155029 |
PSA | 67.79000 |
LogP | 2.72280 |
外观性状 | 白色固体 |
储存条件 | −20°C |
水溶解性 | Slightly soluble |
~53% 盐酸艾司洛尔 81161-17-3 |
文献:Yang, David J.; Oh, Chang-Sok; Kohanim, Saady; Yu, Dong-Fang; Mendez, Richard; Kim, E. Edmund Patent: US2009/238756 A1, 2009 ; Location in patent: Page/Page column 12-13 ; |
~% 盐酸艾司洛尔 81161-17-3 |
文献:Synthetic Communications, , vol. 42, # 5 p. 722 - 726 |
~% 盐酸艾司洛尔 81161-17-3 |
文献:Synthetic Communications, , vol. 42, # 5 p. 722 - 726 |
盐酸艾司洛尔上游产品 4 | |
---|---|
盐酸艾司洛尔下游产品 1 | |
海关编码 | 2922199090 |
---|---|
中文概述 | 2922199090. 其他氨基醇及其醚,酯和它们的盐(但含一种以上含氧基的除外). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装 |
Summary | 2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Esmolol: immunomodulator in pyelonephritis by Pseudomonas aeruginosa.
J. Surg. Res. 198 , 175-84, (2015) Based on previous animal studies showing promising immunomodulatory efficacy esmolol, a selective β1-blocker, it was assumed that administration of esmolol in experimental pyelonephritis by multidrug-... |
|
Effect of Retroperitoneal Lavage with Normal Saline Containing Adrenaline on Carbon Dioxide Absorption in Patients Undergoing Retroperitoneal Laparoscopic Surgery.
J Laparoendosc Adv Surg Tech A 25 , 903-7, (2015) To determine the effect of lavage with adrenaline solution on CO2 absorption during retroperitoneal laparoscopic surgery.Sixty patients scheduled to undergo retroperitoneal laparoscopic surgery were d... |
esmolol hcl |
Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, methyl ester, hydrochloride (1:1) |
Esmolol Hydrochloride |
EsmololHclC16H25No4Hcl |
3-(4-{2-hydroxy-3-[(1-méthyléthyl)amino]propoxy}phényl)propanoate de méthyle chlorhydrate |
Methyl-3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoathydrochlorid |
methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate hydrochloride (1:1) |
benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, methyl ester, hydrochloride |
MFCD00941432 |
methyl 3-(4-{2-hydroxy-3-[(1-methylethyl)amino]propoxy}phenyl)propanoate hydrochloride |
Methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate hydrochloride |
UNII:V05260LC8D |
Methyl 3-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}propanoate hydrochloride (1:1) |
Methyl 3-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}propanoate hydrochloride |
Brevibloc |
Methyl-3-(4-{2-hydroxy-3-[(1-methylethyl)amino]propoxy}phenyl)propanoathydrochlorid |
EsMolol Hcl API |